Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Cosmo Daisey who wrote (3825)	6/30/1998 10:30:00 PM
From: VLAD	Respond to of 9523

Cosmo, You are making several large errors in your blanket math: 1)The Viagra deaths are related only to the time span while on the Viagra--most of these elderly guys are taking Viagra but once a week or so and are under maximum influence for about 4 hours. Four hours a week means that the Viagra is having its effect on 2.38% of the so called life time span. If we take the 30 deaths thus far and divide by .00238 we get 12,605 deaths with constant Viagra use. This IS significant. 2)The Viagra deaths occur along with the normal death rate in humans and is not dependent on "normal" death rates. If the normal death rate (if such a thing exists) is X then who says that the Viagra deaths are calculated as X-(Viagra deaths)? Why not X+(Viagra deaths)? Why cant you place the Viagra deaths on top of the normal rate rather than comparing it to the normal rate? You see the numbers can be looked at from different perspectives. My point is that not so healthy men on other medications are taking Viagra and dying. It is a fact that can no longer be ignored by the FDA. I have no desire to see PFE stock price decline. I do wish to see the hard facts revealed.